ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,127Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 487

$562K Total Retail Price of All Prescriptions

Rank: 26 out of 487

575 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,501 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
FUROSEMIDE 430 394 1 7
POTASSIUM CHLORIDE 388 344 2 10
HYDROCODONE-ACETAMINOPHEN 378 248 S3 3 3
OMEPRAZOLE 378 292 3 2
LISINOPRIL 328 273 5 5
WARFARIN SODIUM 294 265 6 11
LEVOTHYROXINE SODIUM 288 228 7 1
SIMVASTATIN 271 182 8 4
AMLODIPINE BESYLATE 214 214 9 6
METOPROLOL TARTRATE 207 179 10 17
TAMSULOSIN HCL 194 178 11 25
GABAPENTIN 190 148 12 13
METOPROLOL SUCCINATE 178 143 13 15
PREDNISONE 162 137 14 37
HYDROCHLOROTHIAZIDE 159 147 15 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 134 16 24
METFORMIN HCL 142 114 17 8
SERTRALINE HCL 130 122 18 21
ZOLPIDEM TARTRATE 128 73 19 14
DONEPEZIL HCL 127 127 20 38
ATORVASTATIN CALCIUM 118 111 21 18
ADVAIR DISKUS 118 99 21 46
TRAZODONE HCL 109 79 23 22
DIGOXIN 103 101 24 47
CITALOPRAM HBR 101 46 25 12
FLUOXETINE HCL 95 64 26 28
PROAIR HFA 90 36 27 40
RANITIDINE HCL 89 62 28 39
ALLOPURINOL 88 71 29 29
ATENOLOL 86 83 30 23
SPIRONOLACTONE 85 40 31 43
CIPROFLOXACIN HCL 82 77 32 66
IBUPROFEN 82 47 32 78
PRAVASTATIN SODIUM 79 70 34 20
CARVEDILOL 79 72 34 32
QUETIAPINE FUMARATE 76 30 36 69
MELOXICAM 75 53 37 26
TRAMADOL HCL 71 60 38 19
CARBIDOPA-LEVODOPA 70 60 39 85
SPIRIVA 69 49 40 48
COMBIVENT 68 46 41 116
AZITHROMYCIN 68 47 41 50
ALENDRONATE SODIUM 67 62 43 27
KLOR-CON 8 67 62 43 223
NAMENDA 67 67 43 53
FLUTICASONE PROPIONATE 64 57 46 33
ISOSORBIDE MONONITRATE ER 63 62 47 79
CARAFATE 62 62 48 230
VENLAFAXINE HCL ER 58 26 49 55
NAPROXEN 57 36 50 109
ETODOLAC 56 43 51 107
NEXIUM 56 36 51 41
VERAPAMIL ER 56 47 51 114
MIRTAZAPINE 54 42 54 59
AMITRIPTYLINE HCL 53 30 R 55 45
RISPERIDONE 51 26 56 58
LANTUS 51 43 56 44
CLONIDINE HCL 50 38 58 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.